Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
Science (New York, N.Y.)|July 13, 2004
Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaquesDaria J Hazuda, Steven D Young, James P Guare, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2017
Discovery and optimization of 2-pyridinone aminal integrase strand transfer inhibitors for the treatment of HIVJohn D Schreier, Mark W Embrey, Izzat T Raheem, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segmentMin Shu, Jennifer L Loebach, Kerry A Parker, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compoundsDong-Ming Shen, Min Shu, Christopher A Willoughby, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2010
Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1H)-one scaffoldPeter D Williams, Donnette D Staas, Shankar Venkatraman, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2008
10-Hydroxy-7,8-dihydropyrazino[1',2':1,5]pyrrolo[2,3-d]pyridazine-1,9(2H,6H)-diones: potent, orally bioavailable HIV-1 integrase strand-transfer inhibitors with activity against integrase mutantsCatherine M Wiscount, Peter D Williams, Lekhanh O Tran, et al.
Bioorganic & Medicinal Chemistry Letters|December 30, 2006
A potent and orally active HIV-1 integrase inhibitorMelissa S Egbertson, H Marie Moritz, Jeffrey Y Melamed, et al.
The New England Journal of Medicine|July 25, 2008
Raltegravir with optimized background therapy for resistant HIV-1 infectionRoy T Steigbigel, David A Cooper, Princy N Kumar, et al.
The New England Journal of Medicine|July 25, 2008
Subgroup and resistance analyses of raltegravir for resistant HIV-1 infectionDavid A Cooper, Roy T Steigbigel, Jose M Gatell, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2005
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitopeMichael D Miller, Romas Geleziunas, Elisabetta Bianchi, et al.
Pageof 21